Distribution of MDR and XDR typhoidal Salmonella and the association of neutrophil-to-lymphocyte ratio in enteric fever
DOI:
https://doi.org/10.61529/idjp.v34i4.458Abstract
Background: The emergence of extensively drug-resistant Salmonella Typhi poses a global threat. The Neutrophil-to-Lymphocyte Ratio (NLR), an inflammatory marker, has shown prognostic value in various infections but its role in typhoidal Salmonellae is not well established. The objective of the study is to determine the antimicrobial resistance in typhoidal Salmonellae and to evaluate the role of NLR as a clinical biomarker in enteric fever
Material and Methods: Blood cultures from suspected patients of enteric fever were processed from August 2024 to August 2025. Antimicrobial susceptibility was performed by disc diffusion method. NLR was calculated from a complete blood count. ANOVA and Chi-square tests, were used to compare mean NLR across strain types
Results: A total of 450 samples were studied. Among which Typhoidal Salmonellae were isolated from 24.4% of samples. S. Typhi was the predominant serovar (86.3%). Among 90% of resistant isolates, 64.5% were XDR S. Typhi. The overall mean NLR was 2.04 ± 1.14. Statistical analysis revealed no significant difference in mean NLR values (p=0.559) or the distribution of High/Low NLR categories (p=0.87) across the different strain types (MDR, XDR, sensitive).
Conclusion: This study highlights the concerning distribution of drug-resistant Salmonella Typhi. Although the neutrophil-to-lymphocyte ratio does not correlate directly with antimicrobial resistance patterns, it may serves as a strong, readily available prognostic indicator of disease severity. We recommend the routine calculation of NLR to facilitate early identification and timely clinical management of the patient
Keywords: Antimicrobial resistance, Extensively drug-resistant, Multidrug resistance, Salmonella typhi, Neutrophil-to-lymphocyte ratio, Typhoid fever
References
World Health Organization (WHO). (2018). Typhoid vaccines: WHO position paper, March 2018. Weekly Epidemiological Record, 93(13), 153–172.
Britto CD, Wong VK, Dougan G, Pollard AJ. A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. Kang G, editor. PLoS Negl Trop Dis [Internet]. 2018 Oct 11 [cited 2025 Mar 20];12(10):e0006779. Available from: https://dx.plos.org/10.1371/journal.pntd.0006779
Bharmoria A. Typhoid Fever as a Challenge for Developing Countries and Elusive Diagnostic Approaches Available for the Enteric Fever. Int J Vaccine Res [Internet]. 2017 June 2 [cited 2025 Aug 14];2(2):1–16. Available from: https://symbiosisonlinepublishing.com/vaccine-research/vaccine-research18.php
Garrett DO, Longley AT, Aiemjoy K, Yousafzai MT, Hemlock C, Yu AT, et al. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project. Lancet Glob Health [Internet]. 2022 July [cited 2024 Dec 16];10(7):e978–88. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2214109X2200119X
Ali NM, Nasr R, Rehman M, Mahmood SU. Typhoid burden, drug resistance and Pakistan’s stance against it. Int J Community Med Public Health [Internet]. 2021 July 27 [cited 2025 Mar 20];8(8):4082. Available from: https://www.ijcmph.com/index.php/ijcmph/article/view/8299
Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, et al. Emergence of an Extensively Drug-Resistant Salmonella enterica Serovar Typhi Clone Harboring a Promiscuous Plasmid Encoding Resistance to Fluoroquinolones and Third-Generation Cephalosporins. Klugman KP, editor. mBio [Internet]. 2018 Mar 7 [cited 2025 Mar 20];9(1):e00105-18. Available from: https://journals.asm.org/doi/10.1128/mBio.00105-18
Navya P, Begum R, Thajudeen AS, Hussain MA, Vijayashree R. Navigating the Haematological Maze: Unraveling the Role of NLR and PLR as Predictors of Dengue Severity- A Cross-sectional Study from Southern India. J Clin Diagn Res [Internet]. 2024 [cited 2025 Sept 13]; Available from: https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2024&month=March&volume=18&issue=3&page=EC23-EC26&id=19162
Drăgoescu AN, Pădureanu V, Stănculescu AD, Chiuțu LC, Tomescu P, Geormăneanu C, et al. Neutrophil to Lymphocyte Ratio (NLR)—A Useful Tool for the Prognosis of Sepsis in the ICU. Biomedicines [Internet]. 2021 Dec 30 [cited 2025 Sept 21];10(1):75. Available from: https://www.mdpi.com/2227-9059/10/1/75
C Reygaert W, Department of Biomedical Sciences, Oakland University William Beaumont School of Medicine, Rochester, MI, USA. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018];4(3):482–501. Available from: http://www.aimspress.com/article/10.3934/microbiol.2018.3.482
Shi D, Mi G, Wang M, Webster TJ. In vitro and ex vivo systems at the forefront of infection modeling and drug discovery. Biomaterials. 2019 Apr;198:228–49. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0142961218307440
CLSI. Performance standards for antimicrobial susceptibility testing: supplement M100. Clinical and Laboratory Standards Institute, Wayne, PA2023.
Rasheed MK, Hasan SS, Babar ZUD, Ahmed SI. Extensively drug-resistant typhoid fever in Pakistan. Lancet Infect Dis. 2019 Mar ;19(3):242–3. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1473309919300519
Ujjan RA, Shaikh GS, Pathan S, Niamat M, Shaikh F, Ali K. The Effectiveness of Azithromycin versus Cefixime in the Treatment of Typhoid Fever in Children: Azithromycin versus Cefixime in the Treatment of Typhoid Fever. Pak J Health Sci. 2024 Oct 31];179–83. Available from: https://www.thejas.com.pk/index.php/pjhs/article/view/2105
Afzal M, Hassan SS, Sohail S, Camps I, Khan Y, Basharat Z, et al. Genomic landscape of the emerging XDR Salmonella Typhi for mining druggable targets clpP, hisH, folP and gpmI and screening of novel TCM inhibitors, molecular docking and simulation analyses. BMC Microbiol. 2023 Jan 21;23(1):25. Available from: https://bmcmicrobiol.biomedcentral.com/articles/10.1186/s12866-023-02756-6
Butt MH, Saleem A, Javed SO, Ullah I, Rehman MU, Islam N, et al. Rising XDR-Typhoid Fever Cases in Pakistan: Are We Heading Back to the Pre-antibiotic Era? Front Public Health. 2022 Jan 17;9:794868. Available from: https://www.frontiersin.org/articles/10.3389/fpubh.2021.794868/full
Alfhili M, Alazmi S, Alsughayyir J. Correlation of Neutrophil-Lymphocyte Ratio and Critical Illness in Adults on Vancomycin: A Cross-Sectional Study. Int J Gen Med. 2025 July;Volume 18:4157–67. Available from: https://www.dovepress.com/correlation-of-neutrophil-lymphocyte-ratio-and-critical-illness-in-adu-peer-reviewed-fulltext-article-IJGM
Richardson IM, Calo CJ, Ginter EL, Niehaus E, Pacheco KA, Hind LE. Diverse bacteria elicit distinct neutrophil responses in a physiologically relevant model of infection. iScience. 2024 Jan;27(1):108627. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2589004223027049
Kobayashi SD, Malachowa N, DeLeo FR. Neutrophils and Bacterial Immune Evasion. J Innate Immun. 2018;10(5–6):432–41. Available from: https://karger.com/article/doi/10.1159/000487756
Zhang C, Wang X, Tian Y, Niu H, Zhang P, Geng J. Inflammatory markers including NLR, AFR and SII as prognostic factors in neuroblastoma. Sci Rep. 2025 July 6;15(1):24101. Available from: https://www.nature.com/articles/s41598-025-10209-5
Deng H, Wu X, Peng B. Early Predictive Value of Infectious Markers for Ventilator-associated Pneumonia after Stanford Type A Aortic Dissection Surgery. Rev Cardiovasc Med. 2025 Feb 17;26(2):26002. Available from: https://www.imrpress.com/journal/RCM/26/2/10.31083/RCM26002
Tian L, Zhou W, Wu X, Hu Z, Qiu L, Zhang H, et al. CTLs: Killers of intracellular bacteria. Front Cell Infect Microbiol. 2022 Oct 26;12:967679. Available from: https://www.frontiersin.org/articles/10.3389/fcimb.2022.967679/full
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mehveen Iqbal, MUHAMMAD HASSAN, ALISHBA SHABBIR, WAJID HUSSAIN, MAHIN SHAMS
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
